OverviewAI-generated
Organon & Co. is a public company in the pharmaceutical industry. It operates as a Delaware corporation and is listed on the New York Stock Exchange under the ticker symbol OGN. The company is part of the S&P 500 index. Its headquarters are located in Oss, and it maintains a presence in the United States and the Netherlands.
The organization traces its inception to January 1, 1923. It has been associated with parent organizations including Schering-Plough and Merck & Co. Financial data indicates a total revenue of 7777000000 and a net profit of 3218000000. The operating income is recorded at 3696000000. The company’s fiscal year ends on December 31.
Synthesized by Vinony from 24 facts across 4 sources: Wikidata, Firecrawl, SEC EDGAR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
OGN- Industry
- Pharmaceutical Preparations
- Exchange
- NYSE
- Entity type
- operating
- Latest filing
- PREM14A · 2026-06-01
- Jurisdiction
- US-DE
- Headquarters
- JERSEY CITY, US
Wikidata facts
- Instance of
- public company
- Part of
- S&P 500
- Country
- Netherlands
- Headquarters
- Oss
- Parent organization
- Merck & Co.
- Industry
- pharmaceutical industry
- Revenue
- 6174000000
- Stock exchange
- New York Stock Exchange
- Legal form
- Delaware corporation
- Official website
- www.organon.com
Show 5 more facts
- inception
- 1923-01-01
- Commons category
- Organon
- net profit
- 917000000
- operating income
- 1122000000
- short name
- Organon
via Wikidata · CC0
~5 min read
Encyclopedic overview
Organon, here for her health ============================
Excerpted from Wikipedia’s “Organon & Co.” article, available under the CC BY-SA 4.0 licence.
Available in 11 languages
via Wikidata sitelinks · CC0